ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
|
|
- Tracey Smith
- 5 years ago
- Views:
Transcription
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1
2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare 9 mg/ml solution for injection/infusion (IS, DK, FI, SE) Aqupharm Sodium Chloride 9 mg/ml solution for injection/infusion (FR, AT, BE, HU, NL, PL) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance: Sodium Chloride 9 mg The solution provides Sodium: 150 mmol/litre Chloride: 150 mmol/litre For the full list of excipients, see section PHARMACEUTICAL FORM Solution for injection/infusion Clear, colourless particle free solution 4. CLINICAL PARTICULARS 4.1 Target species Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits. 4.2 Indications for use, specifying the target species Correction of water: sodium imbalances. Treatment of metabolic alkalosis. Rehydration in disease conditions which result in excessive loss of water and sodium chloride, and during and after surgery. A vehicle solution for the administration of other compatible drugs. 4.3 Contraindications Do not use in animals with: - sodium and water retention including heart failure, - hypernatraemia, - hyperchloraemia, - hyperhydration 4.4 Special warnings for each target species None 2
3 4.5 Special precautions for use Special precautions for use in animals Use with caution in animals with cardiac or renal impairment as sodium overload may occur. It should be noted that sodium excretion may be impaired post-surgery/trauma. Use with caution in animals with hypokalaemia. Serum electrolyte levels, water and acid-base balance and the clinical condition of the animal should be closely monitored during the treatment in order to prevent overdose, particularly in cases of renal or metabolic changes. A risk of thrombosis with intravenous infusion should be considered. This product should not be used for longer than is necessary to correct and sustain circulating volume. Inappropriate/excessive use may worsen or create a metabolic acidosis. Maintain aseptic precautions. This product does not contain an antimicrobial preservative. The solution should be warmed to approximately 37 C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. The volume and infusion rate must be adapted to the clinical status of each animal. Ensure that the solution is clear and contains no visible particles and the unit is perfectly intact. Otherwise, do not use the solution. Discard any unused portion. Do not exceed maximum dose rate of 90ml/kg/hour. This solution does not contain the appropriate electrolyte balance for longer term maintenance fluid administration Special precautions to be taken by the person administering the veterinary medicinal product to animals None 4.6 Adverse reactions (frequency and seriousness) Not known under normal conditions of use. Where the product is used as a drug carrier, this can lead to other adverse effects. 4.7 Use during pregnancy, lactation or lay The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to the benefit/risk assessment by the responsible veterinarian. 4.8 Interaction with other medicinal products and other forms of interaction It is recommended to take appropriate precautions in animals receiving corticosteroids or corticotrophins to prevent high blood pressure and excessive fluid retention during administration of large volumes. Concomitant administration of colloids requires a dose reduction. 4.9 Amounts to be administered and administration route 3
4 Slow intravenous injection or infusion, or subcutaneous injection. When given subcutaneously, reduced doses are recommended. The amount of fluid and electrolytes to be administered should be calculated by adding the existing deficits to the ongoing maintenance requirements and any ongoing fluid losses (e.g. from vomiting, diarrhoea etc) estimated from the history of the animal, clinical examination and laboratory findings. To calculate the existing fluid deficit, the following equation should be used; Fluid deficit (mls) = Percentage dehydration x Bodyweight (kg) x 10 (e.g. for a 10 kg dog with 5% dehydration the fluid deficit would be 5 x 10 x 10 = 500ml) To calculate the ongoing crystalloid maintenance requirement, the following equation should be used; Maintenance per day for Cattle, Horses, Sheep, Goats, Pigs, Dogs and Cats (mls) = 50ml x Bodyweight (kg) Maintenance per day for Rabbits (mls) = ml x Bodyweight (kg) (e.g. for a 10 kg dog, the daily maintenance fluid requirement is 10 x 50 = 500ml) The administration rate should be adjusted to each animal. The objective is to correct the deficit over hours Overdose (symptoms, emergency procedures, antidotes), if necessary It is recommended to maintain a serum sodium less than or equal to 130 meq / l. In the presence of volume overload signs, treatment should involve administering diuretics and stopping the infusion. Overdose may lead to hypernatraemia, hyperchloraemia, hypokalaemia, cardiac decompensation, hyperhydration and metabolic acidosis. Clinical signs of excessive overdose include restlessness, hypersalivation, shivering, tachycardia, serous nasal discharge, tachypnoea, moist lung sounds, coughing, protrusion of the eye from the orbit, widespread oedema, vomiting and diarrhoea. Long-term infusion may cause electrolyte imbalance. Saline solution is not balanced and it may cause acidaemia because it will increase renal elimination of bicarbonate. Prolonged use may cause hypokalaemia 4.11 Withdrawal period(s) Meat and offal: zero days. Milk: zero hours. 5. PHARMACOLOGICAL IMMUNOLOGICAL PROPERTIES Pharmacotherapeutic group: Solutions affecting the electrolyte balance ATC vet code: QB05BB01 4
5 5.1 Pharmacodynamic properties Sodium chloride and water are normal constituents of the plasma of animals. Sodium is the major cation of the extracellular space and regulates the size of this space together with other anions. The sodium content and the fluid homeostasis of the body are closely related. Each deviation of the plasma sodium concentration from the physiological one simultaneously affects the fluid status of the body. An increase in the sodium content of the body also means reduction of the body's free water content independent of the serum osmolarity. A 0.9 per cent sodium chloride solution has the same osmolarity as plasma. Administration of this solution primarily leads to a replenishment of the interstitial space which is about 2/3 of the entire extracellular space. Only 1/3 of the administered volume remains in the intravascular space. 5.2 Pharmacokinetic particulars Sodium chloride administered by the intravenous route quickly joins the normal distribution and metabolism of sodium chloride and water, in the intracellular and extracellular spaces. Sodium and chloride are normal components of the body and their balance is maintained by the kidneys. The sodium level of the veterinary medicinal product is similar to the physiological level in the serum. The kidneys are the major regulator of the sodium and water balance. In cooperation with the hormonal control mechanisms (renin-angiotensin-aldosterone system, antidiuretic hormone), the kidneys are primarily responsible for the maintenance of a constant volume of the extracellular space and regulation of its fluid composition. Chloride is exchanged for hydrogen carbonate in the tubule system. Thus, it is involved in the regulation of the acid-base balance. 6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Sodium hydroxide (for ph adjustment) Hydrochloric acid (for ph adjustment) Water for injection 6.2 Incompatibilities The compatibility of an added drug with the product must be estimated by monitoring for a color change or appearance of a precipitate of insoluble complexes or crystals. Reference should be made to the SPC of the drug being co-administered for incompatibilities information. Before adding a drug, verify it is soluble and stable in water at the ph of the product. 6.3 Shelf life Shelf life of the veterinary medicinal product as packaged for sale : 100 ml: 2 years 250 m l, 500 ml, 1000 ml, 3000 ml, 5000 ml : 3 years After first opening, use immediately and dispose of any unused product, 6.4. Special precautions for storage 5
6 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml bags do not require any special storage conditions. 100ml bags: Store below 25 ºC 6.5 Nature and composition of immediate packaging Polyvinyl chloride (PVC) bag with polyisoprene/polycarbonate ports, overwrapped with polypropylene. Pack sizes Cardboard box containing 50 bags of 100 ml 30 bags of 250 ml 20 bags of 500 ml 10 bags of 1000 ml 4 bags of 3000 ml 2 bags of 5000 ml Not all pack sizes may be marketed. 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. 7. MARKETING AUTHORISATION HOLDER Animalcare Limited 10 Great North Way York YO26 6RB UK 8. MARKETING AUTHORISATION NUMBER(S) 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 10 DATE OF REVISION OF THE TEXT PROHIBITION OF SALE, SUPPLY AND/OR USE 6
7 ANNEX III LABELLING AND PACKAGE LEAFLET 7
8 A. LABELLING 8
9 PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) NatriumKlorid Animalcare solution for injection/infusion (IS, DK, FI, SE) Aqupharm Sodium Chloride (9 mg/ml) solution for injection/infusion (FR, AT, BE, HU, NL, PL) 2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each ml contains: Sodium Chloride 9mg 3. PHARMACEUTICAL FORM Solution for injection/infusion 4. PACKAGE SIZE 50 x 100ml 30 x 250ml 20 x 500ml 10 x 1000ml 4 x 3000ml 2 x 5000ml 5. TARGET SPECIES Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits. 6. INDICATION(S) 7. METHOD AND ROUTE(S) OF ADMINISTRATION Slow intravenous injection or infusion or subcutaneous injection. Read the package leaflet before use. 8. WITHDRAWAL PERIOD Withdrawal period: Meat and offal: zero days 9
10 Milk: zero hours 9. SPECIAL WARNING(S), IF NECESSARY 10. EXPIRY DATE EXP: DD/MM/YY After first opening, use immediately and dispose of any unused product. 11. SPECIAL STORAGE CONDITIONS 100ml bags: Store below 25 ºC 12. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY Disposal: Read package leaflet 13. THE WORDS FOR ANIMAL TREATMENT ONLY AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE For animal treatment only. To be supplied only on veterinary prescription 14. THE WORDS KEEP OUT OF THE SIGHT AND REACH OF CHILDREN Keep out of the sight and reach of children. 15. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Animalcare Limited 10 Great North Way York YO26 6RB UK 16. MARKETING AUTHORISATION NUMBER(S) 17. MANUFACTURER S BATCH NUMBER Lot {number} 10
11 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Labels 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare solution for injection/infusion (IS, DK, FI, SE) Aqupharm Sodium Chloride (9 mg/ml) solution for injection/infusion (FR, AT, BE, HU, NL, PL) 2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each ml contains: Sodium Chloride 9mg 3. PHARMACEUTICAL FORM Solution for injection/infusion 4. PACKAGE SIZE 100ml 250ml 500ml 1000ml 3000ml 5000ml 5. TARGET SPECIES Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits. 6. INDICATION(S) 7. METHOD AND ROUTE(S) OF ADMINISTRATION IV, SC Read the package leaflet before use. 8. WITHDRAWAL PERIOD Withdrawal period: 11
12 Meat and offal: zero days Milk: zero hours 9. SPECIAL WARNING(S), IF NECESSARY 10. EXPIRY DATE EXP: DD/MM/YY 11. SPECIAL STORAGE CONDITIONS 100ml bags Store below 25 ºC 12. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY 13. THE WORDS FOR ANIMAL TREATMENT ONLY AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE For animal treatment only. To be supplied only on veterinary prescription. 14. THE WORDS KEEP OUT OF THE SIGHT AND REACH OF CHILDREN 15. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Animalcare Limited 10 Great North Way York YO26 6RB UK 16. MARKETING AUTHORISATION NUMBER(S) 17. MANUFACTURER S BATCH NUMBER Lot {number} 12
13 B. PACKAGE LEAFLET 13
14 PACKAGE LEAFLET FOR: Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare solution for injection/infusion (IS, DK, FI, SE) Aqupharm Sodium Chloride (9 mg/ml) solution for injection/infusion (FR, AT, BE, HU, NL, PL) NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder Animalcare Ltd 10 Great North Way York YO26 6RB UK Manufacturer responsible for batch release: Infomed Fluids SRL, 50 Theodor Pallady blvd., District 3, Bucharest, Romania 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare solution for injection/infusion (IS, DK, FI, SE) Aqupharm Sodium Chloride (9mg/ml) solution for injection/infusion (FR, AT, BE, HU, NL, PL) 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each ml contains: Sodium Chloride 9mg Solution for injection/infusion. Clear, colourless particle free solution. 4. INDICATION(S) Correction of water: sodium imbalances. Treatment of metabolic alkalosis. Rehydration in disease conditions which result in excessive loss of water and sodium chloride, and during and after surgery. A vehicle solution for the administration of other compatible drugs. 14
15 5. CONTRAINDICATIONS Do not use in animals with: - sodium and water retention including heart failure, - hypernatraemia, - hyperchloraemia, - hyperhydration 6. ADVERSE REACTIONS Not known under normal conditions of use. Where the product is used as a drug carrier, this can lead to other adverse effects. 7. TARGET SPECIES Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits. 8. DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION Slow intravenous injection or infusion, or subcutaneous injection The amount of fluid and electrolytes to be administered should be calculated by adding the existing deficits to the ongoing maintenance requirements and any ongoing fluid losses (e.g. from vomiting, diarrhoea etc) estimated from the history of the animal, clinical examination and laboratory findings. To calculate the existing fluid deficit, the following equation should be used; Fluid deficit (mls) = Percentage dehydration x Bodyweight (kg) x 10 (e.g. for a 10 kg dog with 5% dehydration the fluid deficit would be 5 x 10 x 10 = 500ml) To calculate the ongoing crystalloid maintenance requirement, the following equation should be used; Maintenance per day for Cattle, Horses, Sheep, Goats, Pigs, Dogs and Cats (mls) = 50ml x Bodyweight (kg) Maintenance per day for Rabbits (mls) = ml x Bodyweight (kg) (e.g. for a 10 kg dog, the daily maintenance fluid requirement is 10 x 50 = 500ml) The administration rate should be adjusted to each animal. The objective is to correct the deficit over hours. When given subcutaneously, reduced doses are recommended. For intravenous infusion, the administration rate should be adjusted to each animal. The objective is to correct the deficit over hours. 15
16 9. ADVICE ON CORRECT ADMINISTRATION 10. WITHDRAWAL PERIOD Meat and offal: zero days Milk: zero hours 11. SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children Do not use this veterinary medicinal product after the expiry date which is stated on the label and carton. The expiry date refers to the last day of that month. After first opening, use immediately and dispose of any unused product. 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml bags do not require any special storage conditions. 100ml bags: Store below 25 ºC 12. SPECIAL WARNING(S) Special warnings for each target species: None Special precautions for use in animals: Use with caution in animals with cardiac or renal impairment as sodium overload may occur. It should be noted that sodium excretion may be impaired post-surgery/trauma. Use with caution in animals with hypokalaemia. Serum electrolyte levels, water and acid-base balance and the clinical condition of the animal should be closely monitored during the treatment in order to prevent overdose, particularly in cases or renal or metabolic changes. A risk of thrombosis with intravenous infusion should be considered. This product should not be used for longer than is necessary to correct and sustain circulating volume. Inappropriate/excessive use may worsen or create a metabolic acidosis. Maintain aseptic precautions. This product does not contain an antimicrobial preservative. The solution should be warmed to approximately 37 C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. The volume and infusion rate must be adapted to the clinical status of each animal. Ensure that the solution is clear and contains no visible particles and the unit is perfectly intact. Otherwise, do not use the solution. Discard any unused portion. Do not exceed maximum dose rate of 90ml/kg/hour. This solution does not contain the appropriate electrolyte balance for longer term maintenance fluid administration. Special precautions to be taken by the person administering the veterinary medicinal product to animals: 16
17 None Use during Pregnancy, Lactation or lay: The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to the benefit/risk assessment by the responsible veterinarian. Interaction with other medicinal products and other forms of interaction: It is recommended to take appropriate precautions in animals receiving corticosteroids or corticotrophins to prevent high blood pressure and excessive fluid retention during administration of large volumes. Concomitant administration of colloids requires a dose reduction. Overdose (symptoms, emergency procedures, antidotes): It is recommended to maintain a serum sodium less than or equal to 130 meq / l. In the presence of volume overload signs, treatment should involve administering diuretics and stopping the infusion. Overdose may lead to hupernatraemia, hyperchloraemia, hypokalaemia, cardiac decompensation, hyperhydration and metabolic acidosis. Clinical signs of excessive overdose include restlessness, hypersalivation, shivering, tachycardia, serous nasal discharge, tachypnoea, moist lung sounds, coughing, protrusion of the eye from the orbit, widespread oedema, vomiting and diarrhoea. Long-term infusion may cause electrolyte imbalance. Saline solution is not balanced and it may cause acidemia because it will increase renal elimination of bicarbonate. Prolonged use may cause hypokalaemia. Incompatibilities: The compatibility of an added drug with the product must be estimated by monitoring for a color change or appearance of a precipitate of insoluble complexes or crystals. Reference should be made to the SPC of the drug being co-administered for incompatibilities information. Before adding a drug, verify it is soluble and stable in water at the ph of the product. 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED 15. OTHER INFORMATION> Polyvinyl chloride (PVC) bag with polyisoprene/polycarbonate ports, overwrapped with polypropylene. 17
18 Pack sizes Cardboard box containing 50 bags of 100 ml 30 bags of 250 ml 20 bags of 500 ml 10 bags of 1000 ml 4 bags of 3000ml 2 bags of 5000ml Not all pack sizes may be marketed. To be supplied only on a veterinary prescription 18
SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 3 Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients Sodium Chloride Glucose Anhydrous
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. SPC-0095-rev02_
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS SPC-0095-rev02_14.07.2011 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT B. Braun Vet Care Hartmann s Lactated Ringers Solution for infusion for cattle, horses,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 50 mg/ml solution for injection for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PT, RO,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CZ, Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle (AT, BE, DE, DK, ES, HU, IE, IT, NL, PL,
More information[Version 8, 10/2012] ANNEX I SUMMARY OF PROPOSED PRODUCT CHARACTERISTICS
[Version 8, 10/2012] ANNEX I SUMMARY OF PROPOSED PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Uniferon 200 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Potassium Chloride
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Piro lyophilisate and solvent for suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Semintra 4 mg/ml oral solution for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active substance:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR suspension for injection for sheep and cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1
More informationANNEX III LABELLING AND PACKAGE LEAFLET
ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Outer carton Multi-pack 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT INCURIN 1 mg tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Sterile Potassium Chloride Concentrate 15%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15% of Potassium Chloride in
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Procycline LA 200 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substance Oxytetracycline (as dihydrate) 200.0
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4, suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Credelio 56 mg chewable tablets for dogs (1.3 2.5 kg) Credelio 112 mg chewable tablets for dogs (>2.5 5.5 kg) Credelio
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RESPIPORC FLUpan H1N1 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of
More information1.3.1 SPC, Labelling and Package Leaflet (Voluven Fresenius 6% Solution for Infusion)
1.3.1 SPC, Labelling and Package Leaflet (Voluven Fresenius 6% Solution for Infusion) 1.3.1 SUMMARY OF PRODUCT CHARACTERISTICS This medicinal product is subject to additional monitoring. This will allow
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DUPHALYTE Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Composition per ml VITAMINS
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ingelvac CircoFLEX suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1 ml)
More information[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Procamidor 20 mg/ml solution for injection (AT, CZ, DE, EE, ES, IT, LT, LV, NL, PT, RO, SI,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bovela lyophilisate and solvent for suspension for injection for cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax Rabies suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationBuserelin animedica mg/ml Injektionslösung für Rinder, Pferde, Kaninchen
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Buserelin animedica 0,004 mg/ml Injektionslösung für Rinder, Pferde, Kaninchen (Germany) Buserelin animedica 0.004 mg/ml Injektionslösung für Rinder, Pferde,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Ducat (DE: Nobivac RC, SE : Nobivac Ducat vet.) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Per
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican DAPPi lyophilisate and solvent for suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Proteq West Nile suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationPART 1.B SPC, LABELLING AND PACKAGE LEAFLET
TRAMADOG, solution for injection Decentralised Procedure D195 February 2018 V3 Tramadol HCl 50 mg/ml Part 1.B SPC, Labelling and Package Leaflet PART 1.B SPC, LABELLING AND PACKAGE LEAFLET 1B- 1 ANNEX
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Myxo-RHD lyophilisate and solvent for suspension for injection for rabbits 2. QUALITATIVE AND QUANTITATIVE
More information3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.
1. NAME OF THE MEDICINAL PRODUCT Albutein 250 g/l, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human albumin Albutein 250 g/l is a solution containing 250 g/l of total protein of
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Albuman 40 g/l is a solution containing 40 g/l (4%) of total protein of which at least 95% is human albumin.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Albuman 40 g/l solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Albuman 40 g/l is a solution containing 40 g/l (4%)
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn PCV suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4 suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval 3 BRSV Pi3 BVD Lyophilisate and suspension for suspension for injection for cattle 2. QUALITATIVE AND QUANTITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis Prequenza suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Circovac emulsion and suspension for emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis Pesti emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis OR inac emulsion for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.25
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Page 1 of 7
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Prilocard 5mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active
More informationPART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET
BIOVETA, a. s. Komenského 212, 683 23 Ivanovice na Hané, Czech Republic, e-mail: obchod@bioveta.cz PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET SUMMARY OF PRODUCT CHARACTERISTICS
More informationSodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride
Package leaflet: Information for the user Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride Read all of this leaflet carefully before using this medicine because it
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Flexbumin 200g/l solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Flexbumin 200 g/l is a solution containing 200 g/l
More informationHartmann s Solution. For Infusion
0xxxxx1_00_HartmannsSolution_IE_BP 07.02.2017 13:15 Seite 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Hartmann s Solution For Infusion Read all of this leaflet carefully before you start using this medicine
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BIOCOM P Vet, suspension for injection for minks (all MS except DK) BIOVAC-BP, suspension for injection for minks (DK) 2.
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 1 ml contains:
More informationB. PACKAGE LEAFLET. Page 1 of 6
B. PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET Prilocard 1.25 mg, 2.5 mg, 5 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Addaven concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Addaven contains: 1 ml 1 ampoule (10 ml) Chromic
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Libromide 325 mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains: Active substance: Potassium
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Coliprotec F4/F18 lyophilisate for oral suspension for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AFTOVAXPUR DOE emulsion for injection for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu-Te Suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP FeLV lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationCOMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)
COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) HUMAN ALBUMIN 20 % BEHRING Rev.: 05-MAR-2008 / PEI approval 26.02.08 Supersedes previous versions Rev.: 28-NOV-2007 / Adaptation to Core SPC Rev.: 02-JAN-2007
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BE, CY, CZ, DE, EL, FR, HU, LU, NL, PT, SK, UK: KELACTIN 50 microgram/ml oral solution for dogs and cats DK, FI, IS, NO, SE:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 20 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cortico Veyxin (BE, BG, CY, CZ, EE, EL, FR, HU, IE, IS, IT, LT, LU, LV, PL, RO, SI, SK, UK) Prednisolon
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioEquin H, emulsion for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vaccine dose (1 ml) contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Spironolactone Ceva 10 mg tablets for dogs Spironolactone Ceva 40 mg tablets for dogs Spironolactone Ceva 80 mg
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT VANGUARD CPV-L 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Quantity per 1 ml dose Active substance(s): Live attenuated canine Parvovirus, strain NL-35-D, low passage,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis StrepE, lyophilisate and solvent for suspension for injection, for horses 2. QUALITATIVE AND QUANTITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINALPRODUCT Oxyglobin 130 mg/ml solution for infusion for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV M Hyo emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 2 ml contains: Active
More information1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
PACKAGE LEAFLET Pronestesic 40 mg/ml / 0.036 mg/ml solution for injection for horses, cattle, pigs and sheep (AT, BE, CY, CZ, DE, DK, EE, EL,ES, HR, IE, IT, LT, LU, LV, NL, PL, PT, SI, SK, UK) Pronestesic
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis Influenza H5N2 emulsion for injection for chickens. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose
More informationIndications: For the treatment and control of fascioliasis in cattle and sheep.
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Zanil Fluke Drench 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active Substance Oxyclozanide 3.4 % w/v Excipients Methyl Parahydroxybenzoate E218 0.15 % w/v Propyl
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Animedazon Spray, 2.45 % w/w cutaneous spray suspension for cattle, sheep and pigs (AT, BE, BG, CZ, CY, DE, DK, EL, ES, FR,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Alburex 5, 50 g/l, solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Alburex 5 is a solution containing 50 g/l of total
More informationPackage leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion
Package leaflet: Information for the user Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Read all of this leaflet carefully before you start using
More informationSUMMARY OF PRODUCT CHARACTERISTICS. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients:
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacrofarm, powder for oral solution, sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients:
More informationPackage leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration
Package leaflet: information for the user Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration Calcium chloride dihydrate/ magnesium chloride hexahydrate/ glucose monohydrate/ lactic
More informationNEW ZEALAND DATA SHEET
1 0.9% Sodium Chloride (infusion, solution) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient 9g/L (0.9%) sodium chloride (USP), in water for injection. For the full list of excipients, see
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oxybee powder and solution for 39.4 mg/ml bee-hive dispersion for honey bees 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 20 mg chewable tablets for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PL, PT, RO, SI,
More informationACETYLCYSTEINE INJECTION
ACETYLCYSTEINE INJECTION 1. Name of the medicinal product Acetylcysteine 200 mg/ml Injection 2. Qualitative and quantitative composition Acetylcysteine 200mg per ml (as N-acetylcysteine) Each 10ml ampoule
More informationBovine Herpes Virus type 1 (BoHV-1), strain Difivac (ge-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Inactivated 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (2ml) contains Active Substance: Bovine Herpes Virus type 1 (BoHV-1), strain
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME ADDAVEN (infusion, solution concentrate) NEW ZEALAND DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 10 ml ampoule of Addaven contains: Chromic chloride hexahydrate 53.33 µg
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Pronestesic 40 mg/ml / 0.036 mg/ml solution for injection for horses, cattle, pigs and sheep (AT, BE, CY, CZ, DE, DK, EE,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Revised: October 2010 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Caninsulin 40 iu/ml Suspension for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS mg (6.85 mg)
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aminoplasmal B. Braun 10% E Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The solution for infusion contains: per
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection
More informationPART I.B. Laboratoire TVM DIAZEPAM TVM / ZIAPAM, 5 MG/ML, SOLUTION FOR INJECTION FOR
PART I.B 1 TABLE OF CONTENT PART I.B: SPC, LABELLING AND PACKAGE INSERT Pages 1.b.1 Summary of product characteristics (SPC)... 3 1.b.2 Labelling and Package... 8 1.b.2.a Labelling... Unchanged 1.b.2.b
More informationPRODUCT INFORMATION. NAME OF THE MEDICINE Compound Sodium Lactate (Hartmann's) Solution for Injection
PRODUCT INFORMATION NAME OF THE MEDICINE Compound Sodium Lactate (Hartmann's) Solution for Injection DESCRIPTION Molecular formulae. Potassium chloride: KCl; sodium chloride: NaCl; calcium chloride dihydrate:
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient KLORUR NATRIUMI Solution for injection 1000 mg / 10 ml (10 %) Solution for injection 85 mg / 10 ml (0.85 %) Solution for infusion 0.9% (Sodium chloride) Read
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PRIMENE 10% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each litre of the infusion solution contains: L-Isoleucine L-Leucine L-Valine
More informationSUMMARY OF PRODUCT CHARACTERISTICS Day 210 Vetmulin 20 g/kg Huvepharma NV
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetmulin 20g/kg Premix for medicated feedingstuff for pigs (UK, IE, NL, BE, IT, HU, RO, CZ, BG, PL) Premezcla medicamentosa para cerdos (ES) Pré-mistura medicamentosa
More information2. What you need to know before you use Compound Sodium Lactate
Package leaflet: Information for the user Compound Sodium Lactate Intravenous Infusion BP, Ecobag (Hartmann s Solution) Read all of this leaflet carefully before you start using this medicine because it
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Citanest with Octapressin Dental 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains Prilocaine Hydrochloride 30 mg (54 mg/1.8
More informationHuman Albumin 200 g/l Baxter is a solution containing 200 g/l of total protein of which at least 95% is human albumin.
1. NAME OF THE MEDICINAL PRODUCT Human Albumin 200 g/l Baxter Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human Albumin 200 g/l Baxter is a solution containing 200 g/l of total protein
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. PolyVar Yellow. Summary of Product Characteristics (SPC)
[Version 8, 10/2012] Version day 210 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS PolyVar Yellow Summary of Product Characteristics (SPC) 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT PolyVar Yellow 275
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn M.hyo - Parasuis, suspension for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: per 2 ml dose Inactivated Mycoplasma
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetmedin 10 mg chewable tablets for dogs. (AT, BG, CY, CZ, EE, EL, HU, IT, LV, LT, PL, RO, SI, SK, ES, LI, PT, BE, LU, NL,
More informationGranisetron Kabi, 1mg/ml, concentrate for solution for injection/infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Granisetron Kabi, 1mg/ml, concentrate for solution for injection/infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains granisetron
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains: Active substance: Inactivated feline leukaemia
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Reconcile 8 mg chewable tablets for dogs Reconcile 16mg chewable tablets for dogs Reconcile 32 mg chewable tablets
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB Primo QX lyophilisate and solvent for suspension for chickens Nobilis IB Primo QX lyophilisate for suspension
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate
PACKAGE LEAFLET: INFORMATION FOR THE USER SODIPHOS 22mEq / 10ml Concentrate for solution for infusion Disodium phosphate dihydrate Read all of this leaflet carefully before you start using this medicine.
More information